Low-dose Interleukin-2 in Combination With Standard Therapy on Idiopathic Inflammatory Myopathy

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
This study aims to explore the clinical and immunological efficacy of low-dose Interleukin-2 (IL-2) and cyclosporin a (CSA) on idiopathic inflammatory myopathy (IIM)
Epistemonikos ID: 89778a7b1fee018c0a73e4aaf75adf13f9cdcf39
First added on: May 07, 2024